89 related articles for article (PubMed ID: 288822)
1. A method for obtaining human bone marrow specimens enriched for myeloblasts and promyelocytes.
Preisler HD; Epstein J
J Lab Clin Med; 1979 Sep; 94(3):414-20. PubMed ID: 288822
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
3. Effects of cytosine arabinoside on unseparated bone marrow and peripheral blood cells and on specimens enriched for myeloblasts and promyelocytes.
Epstein J; Preisler HD; Rustum YM; Higby DJ
Exp Hematol; 1980 Apr; 8(4):404-8. PubMed ID: 7461048
[TBL] [Abstract][Full Text] [Related]
4. Improved method of enrichment for immature myeloid cells from normal human bone marrow.
Burghouts J; Plas AM; Salden M; Wessels J
Exp Hematol; 1980 May; 8(5):515-20. PubMed ID: 7461053
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of progenitor cells from human marrow.
Baines P; Masters G; Booth M; Jacobs A
Exp Hematol; 1987 Aug; 15(7):809-13. PubMed ID: 3609184
[TBL] [Abstract][Full Text] [Related]
6. [Application of sedimentation at 1 g on a Ficoll gradient to the separation of bone marrow cells].
Guerci O; Huot-Marchand F; Schneider O
C R Seances Soc Biol Fil; 1981; 175(2):144-51. PubMed ID: 6454460
[TBL] [Abstract][Full Text] [Related]
7. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
8. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Grant S; Bhalla K; Arlin Z; Howe CW
Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
[TBL] [Abstract][Full Text] [Related]
9. Isolation of pluripotent hemopoietic stem cells and clonable precursor cells of erythrocytes, granulocytes, macrophages and megakaryocytes from mouse bone marrow.
Williams N; Jackson H; Meyers P
Exp Hematol; 1979 Nov; 7(10):524-34. PubMed ID: 317649
[TBL] [Abstract][Full Text] [Related]
10. CFUGEMM, CFUGM, CFUMK: analysis by equilibrium density centrifugation.
Francis GE; Wing MA; Berney JJ; Guimaraes JE
Exp Hematol; 1983 Jul; 11(6):481-9. PubMed ID: 6617785
[TBL] [Abstract][Full Text] [Related]
11. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
Douay L; Lopez M; Gorin NC; Nauman A; Giarratana MC; Laporte JP; Stachowiak J; Salmon C; Duhamel G
Int J Cell Cloning; 1986 Jul; 4(4):250-62. PubMed ID: 2875118
[TBL] [Abstract][Full Text] [Related]
12. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
[TBL] [Abstract][Full Text] [Related]
13. Purification of murine bone-marrow-derived granulocyte-macrophage colony-forming cells.
Williams DE; Straneva JE; Shen RN; Broxmeyer HE
Exp Hematol; 1987 Mar; 15(3):243-50. PubMed ID: 3817051
[TBL] [Abstract][Full Text] [Related]
14. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
[TBL] [Abstract][Full Text] [Related]
15. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil.
Reiner P; Mardiak J; Reinerová M; Ujházy V
Neoplasma; 1981; 28(5):533-9. PubMed ID: 6947140
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
Ball ED; Keefe KA; McDermott JM
Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
[TBL] [Abstract][Full Text] [Related]
18. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
19. Density profiles and purification of chronic myeloid leukemia cells forming colonies in the PHA-leukocyte feeder assay.
Swart K; Hagemeijer A; Löwenberg B
Exp Hematol; 1981 Jul; 9(6):588-94. PubMed ID: 6943037
[TBL] [Abstract][Full Text] [Related]
20. A two-step procedure for obtaining 80-fold enriched suspensions of murine pluripotent hemopoietic stem cells.
Visser JW; Bol SJ
Stem Cells (1981); 1982; 1(4-5):240-9. PubMed ID: 6815814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
